China's National Medical Products Administration (NMPA)

Asia
Pharma

Astellas, GSK-Hansoh, Daiichi—Fierce Pharma Asia

Astellas will close a stem cell therapy site. GSK is launching multiple phase 3 trials for a Hansoh-partnered ADC. Daiichi is selling its OTC business.
Angus Liu Apr 17, 2026 9:15am
Sun Pharma

Sun Pharma's dementia med suspended in China after inspection

Jan 27, 2026 11:47am
newspaper

Padcev-Keytruda result, Alzheimer's med, Fosun—Fierce Pharma Asia

Aug 15, 2025 8:31am
incomplete railroad tracks in namibia

China did not renew approval of controversial Alzheimer's drug

Aug 14, 2025 11:22am
China flag

China approves 4 new drugs, including global 1st-in-class

Jul 2, 2025 11:32am
mazdutide Innovent

Lilly, Innovent's mazdutide nabs first-in-class nod in China

Jun 27, 2025 11:16am